BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9972142)

  • 1. Therapeutic potential of tetracycline derivatives to suppress the growth of abdominal aortic aneurysms.
    Thompson RW; Liao S; Curci JA
    Adv Dent Res; 1998 Nov; 12(2):159-65. PubMed ID: 9972142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
    Thompson RW; Baxter BT
    Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines.
    Curci JA; Petrinec D; Liao S; Golub LM; Thompson RW
    J Vasc Surg; 1998 Dec; 28(6):1082-93. PubMed ID: 9845660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
    Abdul-Hussien H; Hanemaaijer R; Verheijen JH; van Bockel JH; Geelkerken RH; Lindeman JH
    J Vasc Surg; 2009 Mar; 49(3):741-9. PubMed ID: 19268776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms.
    Bigatel DA; Elmore JR; Carey DJ; Cizmeci-Smith G; Franklin DP; Youkey JR
    J Vasc Surg; 1999 Jan; 29(1):130-8; discussion 138-9. PubMed ID: 9882797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal expansion of T cells in abdominal aortic aneurysm: a role for doxycycline as drug of choice?
    Kroon AM; Taanman JW
    Int J Mol Sci; 2015 May; 16(5):11178-95. PubMed ID: 25993290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental aneurysmal degeneration with chemically modified tetracycline derivatives.
    Petrinec D; Holmes DR; Liao S; Golub LM; Thompson RW
    Ann N Y Acad Sci; 1996 Nov; 800():263-5. PubMed ID: 8959009
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical treatment of small abdominal aortic aneurysm.
    Assar AN
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):517-25. PubMed ID: 22854530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
    Kadoglou NP; Liapis CD
    Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of small abdominal aortic aneurysms.
    Baxter BT; Terrin MC; Dalman RL
    Circulation; 2008 Apr; 117(14):1883-9. PubMed ID: 18391122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem.
    Thompson RW
    Curr Opin Cardiol; 1996 Sep; 11(5):504-18. PubMed ID: 8889378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms.
    Sho E; Chu J; Sho M; Fernandes B; Judd D; Ganesan P; Kimura H; Dalman RL
    J Vasc Surg; 2004 Jun; 39(6):1312-21. PubMed ID: 15192574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of novel limited-spectrum MMP inhibitor XL784 in abdominal aortic aneurysms.
    Ennis T; Jin J; Bartlett S; Arif B; Grapperhaus K; Curci JA
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):417-26. PubMed ID: 22894883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms.
    Golub LM; Lee HM; Ryan ME; Giannobile WV; Payne J; Sorsa T
    Adv Dent Res; 1998 Nov; 12(2):12-26. PubMed ID: 9972117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role for anti-angiogenic therapy in abdominal aortic aneurysms.
    Vijaynagar B; Bown MJ; Sayers RD; Choke E
    Eur J Clin Invest; 2013 Jul; 43(7):758-65. PubMed ID: 23672465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms.
    Curci JA; Liao S; Huffman MD; Shapiro SD; Thompson RW
    J Clin Invest; 1998 Dec; 102(11):1900-10. PubMed ID: 9835614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB.
    Parodi FE; Mao D; Ennis TL; Bartoli MA; Thompson RW
    J Vasc Surg; 2005 Mar; 41(3):479-89. PubMed ID: 15838484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastin stabilization for treatment of abdominal aortic aneurysms.
    Isenburg JC; Simionescu DT; Starcher BC; Vyavahare NR
    Circulation; 2007 Apr; 115(13):1729-37. PubMed ID: 17372168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.
    Mosorin M; Juvonen J; Biancari F; Satta J; Surcel HM; Leinonen M; Saikku P; Juvonen T
    J Vasc Surg; 2001 Oct; 34(4):606-10. PubMed ID: 11668312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an inhibitor of matrix metalloproteinases on spontaneous osteoarthritis in guinea pigs.
    de Bri E; Lei W; Svensson O; Chowdhury M; Moak SA; Greenwald RA
    Adv Dent Res; 1998 Nov; 12(2):82-5. PubMed ID: 9972127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.